Two cases of Erythrodermic psoriasis treated with Golimumab

INTRODUCTION AND IMPORTANCE: Erythrodermic psoriasis (EP) is a very severe subtype of psoriasis, with a challenge poses in its treatment, as currently available therapies often provide unsatisfactory results, for those many biologics have been used in the treatment of EP such as Golimumab which has...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudsi, Mayssoun, Alzabibi, Mhd Amin, Shibani, Mosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207129/
https://www.ncbi.nlm.nih.gov/pubmed/35734731
http://dx.doi.org/10.1016/j.amsu.2022.103961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207129/
https://www.ncbi.nlm.nih.gov/pubmed/35734731
http://dx.doi.org/10.1016/j.amsu.2022.103961

Ejemplares similares